News

Yahoo Finance3mon
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer - Yahoo Finance
The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor in ...
Yahoo Finance6mon
BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer - Yahoo Finance
The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus an immune check point inhibitor in ...
Nasdaq3mon
Belite Bio's Phase 3 DRAGON Trial for Tinlarebant Recommended to Continue Without Modifications by Data Safety Monitoring Board - Nasdaq
Belite Bio, Inc. announced that the independent Data Safety Monitoring Board (DSMB) recommended the continuation of the Phase 3 DRAGON trial for Tinlarebant, an experimental treatment for ...
Business Wire1mon
Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint - Business Wire
Prothena today announced the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with AL amyloidosis did not meet its primary endpoint. ... Chair of Prothena’s Board of Directors.